Kanglaite is used to treat patients before surgery or inoperable patients with spleen deficiency and damp stagnation type of primary Non-small-cell lung cancer .
Nourishing Qi and Yin,eliminating and resolving stagnation and masses.
Used to treat patients before surgery or inoperable patients with spleen deficiency and damp stagnation type of primary Non-small-cell lung cancer .
Kanglaite capsule has synergistic effect on chemotherapy for late stage non-small cell lung cancer , have certain resistance in patients with middle-late tumor cachexia and analgesic effect. Kanglaite soft capsule could relieve patients' pain and improve the quality of survival.
What is KLT?
A: With its active ingredient extracted from seed of “semen coicis”, a natural anti-tumor herbal plant, Kanglaite Injection (KLT) is a novel dual-function, broad spectrum and molecular-targeting anti-neoplastic formulation for intravenous and intra-arterial application. KLT can directly inhibit and kill cells of various tumors, control lesions, and prevent metastasis. Simultaneously it is able to protect normal cells and improve immune function. In addition KLT presents significant role in relieving cancerous pain and cachexia and improving clinical symptoms so as to upgrade patient quality of life and prolong survival. KLT can be used alone or combined with chemotherapy or radiation therapy or applied peri-operationally. The combination therapy is able to remarkably enhance effect of chemotherapy or radiotherapy, prevent and minimize toxic side effect of these therapies and raise resection rate in operation. Therefore KLT is an ideal anticancer drug.
What are the major indications of KLT?
A: Various stages primary lung cancer including NSCLC, primary hepatic cancer, pancreatic cancer and lymphoma. KLT has satisfactory therapeutic effect on various advanced tumors in palliative treatment in addition to its unique effect on cachexia and cancerous pain.
What is the active substance in KLT?
A: It is coix triglyceride that is already patented in 11 countries and regions in the world.
Not for use during pregnancy.
Shelf-life: 30 months
Executive standard: Chinese Pharmacopoeia 2010, volumeⅠ.
Manufacturer: Company name: Shijiazhuang Yiling Pharmaceutical Co., Ltd.
|Product Name||Kanglaite soft capsules, kanglaite ruan jiaonang|
|Ingredients||Triglyceride of Coix seed oil|
|Indications||Kanglaite is used to treat patients before surgery or inoperable patients with spleen deficiency and damp stagnation type of primary Non-small-cell lung cancer .|
|Dosage||6 capsules per time; 4 times daily. The product is preferably used in combination with radiotherapy or chemotherapy.|
|CFDA approval number||Z20040138|
|Storage||Closed and keep in cool and dry place.|
|Note||This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.|
6 capsules per time; 4 times daily. One month is recommended. The product is preferably used in combination with radiotherapy or chemotherapy.
Experience package including 5 packs with 360 capsules which may last 12 days.
1 course package including 10 packs with 720 tablets which may last 24 days.